background image

Paid Clinical Trials Rochester

Discover 393 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Observational Study

Recruiting

Sponsor:

Arbor Research Collaborative for Health

Location:

Rochester NY, Toronto, Pittsburgh PA, Hackensack NJshow 35 more

Code:

NCT04970056

Conditions

Pancreas Cancer

Pancreas Cyst

Pancreatic Ductal Adenocarcinoma

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

Recruiting

Sponsor:

University of Iowa

Location:

Rochester NY, Philadelphia PA, Hartford CT, Ann Arbor MIshow 3 more

Code:

NCT01203085

Conditions

Charcot Marie Tooth Disease

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Alisertib & Endocrine Therapy

Recruiting
PHASE2

Sponsor:

Puma Biotechnology, Inc.

Location:

Rochester NY, Pittsburgh PA, Horsham PA, Philadelphia PAshow 25 more

Code:

NCT06369285

Conditions

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Recurrent Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alisertib

Endocrine therapy

Nail Genesis

Recruiting

Sponsor:

Nail Genesis LLC

Location:

Rochester NY, Lynchburg VA, Fayetteville AR, South Miami FLshow 5 more

Code:

NCT06074315

Conditions

Distal Lateral Subungual Onychomycosis

Onychomycosis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Nail Genesis DLSO Product

Nail Genesis DLSO Product (vehicle only)

Anifrolumab

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Rochester NY, Hamilton, Cleveland OH, New York NYshow 34 more

Code:

NCT06015737

Conditions

Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Anifrolumab

Placebo

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Observational Study

Recruiting

Sponsor:

University of Maryland, Baltimore

Location:

Rochester NY, London, Montreal, Springfield MAshow 13 more

Code:

NCT05300737

Conditions

Carotid Stenosis

Ischemic Stroke

Transient Ischemic Attack

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

intensive medical therapy

Inebilizumab

Recruiting
PHASE2

Sponsor:

University of Utah

Location:

Rochester NY, Williamsville NY, Pittsburgh PA, New York NYshow 27 more

Code:

NCT04372615

Conditions

Autoimmune Encephalitis

Encephalitis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Inebilizumab

Placebo

Remibrutinib

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Rochester NY, Richmond Hill, Hamilton, Pittsburgh PAshow 34 more

Code:

NCT06799000

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Remibrutinib Dose A

Remibrutinib Dose B

Placebo 1

Placebo 2

VTA Ablation

Recruiting

Sponsor:

University of Rochester

Location:

Rochester NY

Code:

NCT05034432

Conditions

Arrythmia

Cardiomyopathies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intra-Op Prophylactic VT ablation

Conventional Management

NMD670

Recruiting
PHASE2

Sponsor:

NMD Pharma A/S

Location:

Rochester NY, New York NY, Boston MA, Columbus OHshow 4 more

Code:

NCT06482437

Conditions

Charcot-Marie-Tooth Disease

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

NMD670

Placebo